Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jun 15, 2023
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Codexis, Inc.
| 34.6K |
—
|
—
| +101.85% | 68.58K |
Jun 13
| |||||||
Allogene Therapeutics, Inc.
| 558.09K |
—
|
—
| +486.84% | 672.73K |
Mar 22
| |||||||
Allogene Therapeutics, Inc.
| -8.35K |
$5.51 | -$45,989.79 | -6.79% | 114.64K |
Mar 14
| |||||||
Codexis, Inc.
| 11.27K |
—
|
—
| +49.66% | 33.97K |
Jun 14
| |||||||
Allogene Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
|
Mar 23
| |||||||
Allogene Therapeutics, Inc.
| -8.70K |
$7.63 | -$66,388.35 | -6.74% | 120.43K |
Mar 15
| |||||||
4.8K |
—
|
—
| +26.79% | 22.7K |
Jun 15
| ||||||||
Allogene Therapeutics, Inc.
| 24.87K |
—
|
—
| +24.24% | 127.44K |
Mar 26
| |||||||
Allogene Therapeutics, Inc.
| -6.16K |
$38.14 | -$235,089.41 | -5.67% | 102.57K |
Mar 15
| |||||||
Allogene Therapeutics, Inc.
|
0
|
$22.14 | -$1,401,038.72 |
—
| 108.37K |
Oct 12 - Oct 13
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
| -9.31K |
$21.64 | -$1,747,484.72 | -7.91% | 108.37K |
Oct 8 - Oct 9
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
| -9.31K |
$21.14 | -$1,702,910.72 | -3.23% | 279.22K |
Oct 6
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
| 32.45K |
$2.27 | $73,663.77 | +34.59% | 126.27K |
Aug 13
| |||||||
17.91K |
—
|
—
|
∞
| 17.91K |
Jun 16
| ||||||||
0
|
—
|
—
|
—
|
0
| |||||||||
Allogene Therapeutics, Inc.
| 30.8K |
—
|
—
| +48.87% | 93.82K |
Mar 18
| |||||||
Allogene Therapeutics, Inc.
| -3.75K |
$19.19 | -$71,980.12 | -5.62% | 63.02K |
Mar 16
| |||||||
Allogene Therapeutics, Inc.
|
0
|
$17.19 | -$1,456,828.95 |
—
| 66.07K |
Sep 16 - Sep 18
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
|
0
|
$15.86 | -$1,326,765.39 |
—
| 65.37K |
Jul 26 - Jul 30
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
| 27.82K |
$2.27 | $63,142.32 | +74.06% | 65.37K |
Jun 28
| |||||||
Allogene Therapeutics, Inc.
|
0
|
$14.52 | -$1,195,934.78 |
—
| 37.56K |
Jun 3
|
Scheduled
| ||||||
Allogene Therapeutics, Inc.
| 37.05K |
—
|
—
|
∞
| 37.05K |
Mar 13
| |||||||
Allogene Therapeutics, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. | |||||||||||||
Want to view more results?
Unlock the hidden results with your Benzinga Account now. No purchase required.